GlassScriptPhysician profile
Gregory W Botteron
NPI 1215933106
$52,071.32
in general payments reported to CMS, 2019-2025
29 companies · $902 in 2025
The $902 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $25K · 2020: $7,095 · 2021: $2,700 · 2022: $4,148 · 2023: $5,920 · 2024: $6,007 · 2025: $902.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Travel and Lodging: $1,928.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,901.66 |
| Travel and Lodging | $1,927.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $17,705.05 | 2019-2024 | Xarelto |
| Abbott Laboratories | $11,789.71 | 2019-2025 | Amplatzer Amulet, Aveir, Ensite |
| Boston Scientific Corporation | $8,309.54 | 2019-2025 | Watchman Access System, Rhythmia Mapping System, Watchman Flx |
| Pfizer INC. | $7,906.10 | 2019-2024 | |
| Biosense Webster, INC. | $2,776.17 | 2019-2025 | Carto 3, Octaray Mapping Catheter, Qdot Micro Catheter |
| Medtronic, INC. | $977.65 | 2021-2025 | Linq II, Closurefast, Cobalt Dr Mri Surescan |
| E.R. Squibb & Sons, L.L.C. | $865.39 | 2019-2025 | Eliquis, Camzyos |
| Sanofi-Aventis U.S. LLC | $359.43 | 2019-2024 | |
| Medtronic Vascular, INC. | $231.38 | 2019 | |
| Abiomed | $170.49 | 2021-2024 | Impella |
| Itamar Medical INC | $164.59 | 2022-2023 | Watchpatone |
| Flowphysix INC | $150.05 | 2025 | Flowrunner |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $96.38 | 2019-2022 | |
| Volta Medical INC | $69.99 | 2024 | Vx1 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $66.43 | 2019-2024 | Jardiance |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kiniksa Pharmaceuticals, LTD. | $64.48 | 2023 | Arcalyst |
| Novartis Pharmaceuticals Corporation | $63.81 | 2022-2023 | |
| Kestra Medical Technology Services, INC. | $51.27 | 2024-2025 | Assure Wcd |
| Cardiva Medical, INC. | $47.51 | 2021-2022 | |
| Siemens Medical Solutions USA, INC. | $44.36 | 2023 | Acuson S2000 Diagnostic Ultrasound System |
| Csl Behring | $27.11 | 2023 | Kcentra |
| Astrazeneca Pharmaceuticals LP | $21.88 | 2024 | Wainua |
| Novo Nordisk INC | $21.36 | 2025 | Wegovy |
| Irhythm Technologies, INC. | $21.08 | 2023 | Zio Xt Patch |
| Actelion Pharmaceuticals US, INC. | $15.72 | 2023 | Uptravi, Opsumit |
| Amarin Pharma, INC. | $14.52 | 2020 | |
| Teleflex LLC | $13.82 | 2023 | Vascband |
| Cvrx, INC. | $13.39 | 2023 | Barostim Neo System |
| Merck Sharp & Dohme LLC | $12.66 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Botteron listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.